AI English summary of an SEC filing — figures as filed
Intuitive Surgical ISRGThe company said da Vinci procedures performed by its customers grew about 15% over the 3 months ended June 30, 2026, lower than about 17% a year earlier. U.S. procedures grew about 12%, and procedures outside the U.S. (OUS) grew about 20%.
Key points
AI summaryThe company said da Vinci procedures performed by its customers grew about 15% over the 3 months ended June 30, 2026, lower than about 17% a year earlier. U.S. procedures grew about 12%, and procedures outside the U.S. (OUS) grew about 20%.
Intuitive said it placed 468 da Vinci systems in Q2 2026, up from 395 in Q2 2025. Of these, 246 were da Vinci 5 systems, compared with 180 a year earlier. The company also said its da Vinci installed base was about 11,710 systems as of June 30.
The company said operating lease revenue was $262 million for Q2 2026, compared with $214 million a year earlier, and that variable lease revenue within that total was $169 million. It also said Ion biopsy procedures were about 47,900 in the same quarter, compared with about 35,300 a year earlier.
The company said that for the 6 months ended June 30, 2026, operating cash flow was $1.97 billion and net income was $1.65 billion. It said it used $1.44 billion for share repurchases and $528 million for business acquisitions.
Key figures
Quarter ended June 30, 2026
- Revenue
- $2.9B
- Operating income
- $972M
- Net income
- $818M
- EPS
- $2.29
- Gross profit
- $2.0B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
da Vinci Procedure Growth Rate
The company said da Vinci procedures performed by its customers grew about 15% over the 3 months ended June 30, 2026, lower than about 17% a year earlier. U.S. procedures grew about 12%, and procedures outside the U.S. (OUS) grew about 20%.
Source · Based on the MD&A text of the filing
da Vinci 468 System Placements
Intuitive said it placed 468 da Vinci systems in Q2 2026, up from 395 in Q2 2025. Of these, 246 were da Vinci 5 systems, compared with 180 a year earlier. The company also said its da Vinci installed base was about 11,710 systems as of June 30.
Source · Based on the MD&A text of the filing
Operating Lease Revenue and Ion Procedures
The company said operating lease revenue was $262 million for Q2 2026, compared with $214 million a year earlier, and that variable lease revenue within that total was $169 million. It also said Ion biopsy procedures were about 47,900 in the same quarter, compared with about 35,300 a year earlier.
Source · Based on the MD&A text of the filing
6-Month Cash Flow and Liquidity
The company said that for the 6 months ended June 30, 2026, operating cash flow was $1.97 billion and net income was $1.65 billion. It said it used $1.44 billion for share repurchases and $528 million for business acquisitions.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…